Výsledky vyhledávání - "Tom, Sheidow"

Maximal Extension Interval and Visual Outcomes in a Treat-and-Extend Protocol: A Post-Hoc Analysis of the CANTREAT Randomized Trial

Autor: Marko M. Popovic, Tom Sheidow, Jason Baker, Peter J. Kertes

Publikováno v: Ophthalmologica.

Introduction: The Canadian Treat-and-Extend Analysis Trial with Ranibizumab (CANTREAT), was a 2-year, multicentred, randomized clinical trial (RCT) to evaluate treat-and-extend (T&E) relative to monthly administration of ranibizumab in neovascular ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cfa96ab4ceb203a929dcf23b92f71391
https://doi.org/10.1159/000530364

Zobrazit plný text záznamu

The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis

Autor: Keean, Nanji, Gurkaran S, Sarohia, Kevin, Kennedy, Tiandra, Ceyhan, Tyler, McKechnie, Mark, Phillips, Tahira, Devji, Lehana, Thabane, Peter, Kaiser, David, Sarraf, Sunir J, Garg, Sobha, Sivaprasad, Charles C, Wykoff, Sophie J, Bakri, Tom, Sheidow, Mohit, Bhandari, Varun, Chaudhary

Publikováno v: Ophthalmology. 129(5)

To investigate the effect of anti-vascular endothelial growth factor (VEGF) therapy on intraocular pressure (IOP) 12 and 24 months after initiation.It is unclear whether serial anti-VEGF injections result in sustained IOP increases.Randomized control

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c35022366ba7ae53911cb07125ad9f84
https://pubmed.ncbi.nlm.nih.gov/34871637

Zobrazit plný text záznamu

Long-Term Efficacy of a Treat-and-Extend Regimen with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: An Open-Label 12-Month Extension to the CANTREAT Study

Autor: Peter J, Kertes, Tom, Sheidow, Geoff, Williams, Mark, Greve, Ivan J, Galic, Jason, Baker

Publikováno v: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 245(3)

Introduction: The objective of this study is to assess the long-term effectiveness of a treat-and-extend (T&E) anti-vascular endothelial growth factor regimen in patients with neovascular age-related macular degeneration who remain on T&E and those s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc9a792d632ee7235dcb6e7d3262b89
https://pubmed.ncbi.nlm.nih.gov/34969033

Zobrazit plný text záznamu

Identifying gaps in patient access to diabetic screening eye examinations in Ontario: a provincially representative cross-sectional study

Autor: David T. Wong, Brian G. Ballios, Teresa Park, Tom Sheidow, Richard H. Glazier, Bernard Hurley, Alan F. Cruess, Michael H. Brent, Varun Chaudhary, Stephen Kosar

Publikováno v: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 56(4)

Objective Diabetes is the leading cause of acquired blindness in Canadians under the age of 50 years, and diabetic retinopathy affects an estimated 500 000 Canadians. Early identification of retinopathy with screening eye examinations allows for seco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8f5e9d327004610e859c73efaec042
https://pubmed.ncbi.nlm.nih.gov/33232680

Zobrazit plný text záznamu

Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee

Autor: Varun Chaudhary, Amin Kherani, Arif Samad, Tom Sheidow, Marie Carole Boucher, Ravi I. Dookeran, Renaud Duval, Michael H. Brent, D. Maberley, David T. Wong, J. Qian

Publikováno v: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 55(1 Suppl 1)

Objective The purpose of this report is to develop a consensus for Canadian national guidelines specific to a tele-medicine approach to screening for diabetic retinopathy (DR) using evidence-based and clinical data. Methods Canadian Tele-Screening Gr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff612abf6a807cff92f6313f530cbf5
https://pubmed.ncbi.nlm.nih.gov/32089161

Zobrazit plný text záznamu

Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease: One-Year Results of the Randomized Canadian Treat-and-Extend Analysis Trial with Ranibizumab Study

Autor: Peter J, Kertes, Ivan J, Galic, Mark, Greve, R Geoff, Williams, Emmanouil, Rampakakis, Andrea, Scarino, Tom, Sheidow

Publikováno v: Ophthalmology. 126(6)

To compare the efficacy of ranibizumab using a treat-and-extend (TE) regimen with monthly dosing in treatment-naive patients with neovascular age-related macular degeneration (nAMD).Prospective, randomized, open-label, multicenter, noninferiority, po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c1624d54cfcb154886bde0473c2b45ab
https://pubmed.ncbi.nlm.nih.gov/30677465

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání